Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Inmunova S.A.
Sponsor

Inmunova S.A.

Paraguay 1535

About the sponsor

Inmunova S.A. focuses its clinical research on Hemolytic Uremic Syndrome, with particular attention to pediatric disease linked to Shiga toxin-producing Escherichia coli. The sponsor’s activity is centered on renal complications associated with this condition and the clinical management of toxin-mediated injury.

  • Renal involvement
  • Pediatric nephrology
  • Shiga toxin-associated infection

Its research landscape reflects interest in treatments aimed at improving kidney-related outcomes in acute toxin-driven disease.

About Specializations

Inmunova S.A. runs clinical trials in conditions such as Haemolytic uraemic syndrome, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

1 clinical trial

Haemolytic uraemic syndrome

Recruiting
Investigational
Countries:BelgiumBelgium
  • Participants:0–17 years
  • Substances:Equine Immunoglobulin F(Ab')2 Fragments Targeting Shiga Toxin
  • Sponsor:Chemo Research S.L.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.